These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 30458338

  • 21. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H, Gabazza E, Nakasaki T, Shimura M, Hiyoyama K, Deguchi K, Nishikawa M, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 2000; 26(1):17-21. PubMed ID: 10805276
    [Abstract] [Full Text] [Related]

  • 22. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [Abstract] [Full Text] [Related]

  • 23. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S.
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
    Asakura H, Wada H, Okamoto K, Iba T, Uchiyama T, Eguchi Y, Kawasugi K, Koga S, Mayumi T, Koike K, Gando S.
    Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
    [Abstract] [Full Text] [Related]

  • 25. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K, Fujimaki M.
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [Abstract] [Full Text] [Related]

  • 26. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H.
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [Abstract] [Full Text] [Related]

  • 27. Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.
    Li J, Zhou J, Ren H, Teng T, Li B, Wang Y, Xiang L.
    Clin Appl Thromb Hemost; 2022 Apr; 28():10760296221102929. PubMed ID: 35603624
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Apr; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 29. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T, Aoki N.
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [Abstract] [Full Text] [Related]

  • 30. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H, Mori Y, Shimura M, Hiyoyama K, Ioka M, Nakasaki T, Nishikawa M, Nakano M, Kumeda K, Kaneko T, Nakamura S, Shiku H.
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [Abstract] [Full Text] [Related]

  • 31. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T.
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [Abstract] [Full Text] [Related]

  • 32. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
    Koyama T, Kakishita E, Nakai Y, Okamoto E.
    Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
    [Abstract] [Full Text] [Related]

  • 33. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K, Zhao LJ, Shirakawa S.
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H, Yamamuro M, Inoue A, Shiku H, Sakuragawa N, Redl H, Peer G, Taylor FB.
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the diagnostic value of coagulation markers and coagulation function indices on the occurrence of DIC in sepsis and its prognosis.
    Fang X, Fu W, Xu L, Qiu Y.
    Allergol Immunopathol (Madr); 2024 Dec; 52(5):65-72. PubMed ID: 39278853
    [Abstract] [Full Text] [Related]

  • 36. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T, Matsuo M, Sugimoto T, Wanaka K.
    Pathophysiol Haemost Thromb; 2007 Dec; 36(6):305-10. PubMed ID: 20224256
    [Abstract] [Full Text] [Related]

  • 37. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K.
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [Abstract] [Full Text] [Related]

  • 38. Hemostatic study before onset of disseminated intravascular coagulation.
    Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi A, Mori Y, Deguchi K.
    Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
    [Abstract] [Full Text] [Related]

  • 39. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
    Ji Y, Qin Y, Tan Q, Qiu Y, Han S, Qi X.
    BMC Biotechnol; 2024 May 08; 24(1):30. PubMed ID: 38720310
    [Abstract] [Full Text] [Related]

  • 40. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
    Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A.
    Am J Hematol; 1990 Feb 08; 33(2):90-5. PubMed ID: 1689102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.